Literature DB >> 11154146

Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency.

S Akhavan1, P M Mannucci, M Lak, G Mancuso, M G Mazzucconi, A Rocino, P V Jenkins, S J Perkins.   

Abstract

Prothrombin deficiency is an autosomal recessive disorder associated with a moderately severe bleeding tendency. In this study, 13 patients with prothrombin deficiency were screened for the presence of alterations in the prothrombin gene, and nine novel candidate mutations were identified. Of 11 patients with hypoprothrombinemia, ten are homozygous for five mutations and one patient is a compound heterozygote. The two patients with dysprothrombinemia are homozygous for two mutations. Eight of nine mutations are missense ones associated with single amino acid substitutions in the propeptide (Arg-1Gln, Arg-2Trp), the kringle-1 (Asp118Try) and kringle-2 (Arg220Cys) domains and the catalytic serine protease domain (Gly330Ser, Ser354Arg. Arg382His and Arg538Cys). The ninth mutation is an in-frame deletion of 3 bp that results in the omission of one amino acid (del Lys 301/302). The combination of these missense mutations with crystal structures for alpha-thrombin and the prothrombin fragments 1 and 2 resulted in new insight into the function of alpha-thrombin. The hypoprothrombinemia mutations were inferred to affect either the cleavage of the propeptide from the Gla domain, the stability of the kringle-1 and -2 domains, or the close association of the A and B chains of the serine protease domain. The dysprothrombinemia mutations were inferred to directly affect catalytic function through their location at the active site crevice or exosite 1 within the serine protease domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154146

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.

Authors:  Chang C Liu; Eric Brustad; Wenshe Liu; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2007-08-09       Impact factor: 15.419

2.  Dual effect of histone H4 on prothrombin activation.

Authors:  N Pozzi; E Di Cera
Journal:  J Thromb Haemost       Date:  2016-08-11       Impact factor: 5.824

3.  An in vitro anticoagulant effect of Fenugreek (Trigonella foenum-graecum) in blood samples of normal Sudanese individuals.

Authors:  Imadeldin M Taj Eldin; Majed M Abdalmutalab; Haydar E Bikir
Journal:  Sudan J Paediatr       Date:  2013

4.  Probing light chain mutation effects on thrombin via molecular dynamics simulations and machine learning.

Authors:  Jiajie Xiao; Ryan L Melvin; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2018-03-02

5.  Molecular dynamics simulations of aptamer-binding reveal generalized allostery in thrombin.

Authors:  Jiajie Xiao; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2016-11-29

6.  Na+-binding modes involved in thrombin's allosteric response as revealed by molecular dynamics simulations, correlation networks and Markov modeling.

Authors:  Jiajie Xiao; Freddie R Salsbury
Journal:  Phys Chem Chem Phys       Date:  2019-02-20       Impact factor: 3.676

7.  Role of the A chain in thrombin function.

Authors:  M E Papaconstantinou; A Bah; E Di Cera
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 8.  Thrombin.

Authors:  Enrico Di Cera
Journal:  Mol Aspects Med       Date:  2008-02-01

9.  Light Chain Mutation Effects on the Dynamics of Thrombin.

Authors:  Dizhou Wu; Jiajie Xiao; Freddie R Salsbury
Journal:  J Chem Inf Model       Date:  2021-01-15       Impact factor: 4.956

10.  Thrombin a-chain: activation remnant or allosteric effector?

Authors:  Isis S R Carter; Amanda L Vanden Hoek; Edward L G Pryzdial; Ross T A Macgillivray
Journal:  Thrombosis       Date:  2010-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.